Order Article Reprints

Ozcan B, Blachot-Minassian B, Paradis S, Mazière L, Chambion-Diaz M, Bouyon S, Pépin J-L, Pialoux V, Arnaud C, Moinard C, et al. L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome. Antioxidants. 2022; 11(12):2326. https://doi.org/10.3390/antiox11122326

Ozcan, Bilgehan, Britanny Blachot-Minassian, Stéphanie Paradis, Lucile Mazière, Marie Chambion-Diaz, Sophie Bouyon, Jean-Louis Pépin, Vincent Pialoux, Claire Arnaud, Christophe Moinard, and et al. 2022. "L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome" Antioxidants 11, no. 12: 2326. https://doi.org/10.3390/antiox11122326

Ozcan, B., Blachot-Minassian, B., Paradis, S., Mazière, L., Chambion-Diaz, M., Bouyon, S., Pépin, J.-L., Pialoux, V., Arnaud, C., Moinard, C., & Belaidi, E. (2022). L-Citrulline Supplementation Reduces Blood Pressure and Myocardial Infarct Size under Chronic Intermittent Hypoxia, a Major Feature of Sleep Apnea Syndrome. Antioxidants, 11(12), 2326. https://doi.org/10.3390/antiox11122326